Plasmatic and Platelet Anti-Plasmins and Anti-Activators
- 1 January 1967
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 18 (03/04) , 404-415
- https://doi.org/10.1055/s-0038-1655049
Abstract
Direct antiplasmin and anti-urokinase can be measured with artificial clots to which plasma, serum or platelet suspension is added incubated in plasmin or urokinase respectively. Whilst only 3% of the total antiplasmin in the blood is present in the platelets, there is 40% of the total antiurokinase present in the platelets. The properties of this thrombocytic anti-urokinase are discussed. Only 60% is soluble in water. By heating this solution the inhibiting effect increases. Platelet anti-activator is also active against other activators but has not the same properties as anti-urokinase. Implications of these findings are discussed.Funding Information
- Netherlands Organisation for pure scientific research
This publication has 8 references indexed in Scilit:
- Studies on the fibrinolytic enzyme system in obesityJournal of Clinical Pathology, 1966
- Effects of Major Surgery on Plasmin-Plasminogen InhibitorsArchives of internal medicine (1960), 1961
- Antiplasmin Deficiency in Polycythaemia: a Form of ThrombopathyThrombosis and Haemostasis, 1961
- Antifibrinolytic Activity of Certain PectinsThrombosis and Haemostasis, 1961
- Influence of Blood Platelets on FibrinolysisThrombosis and Haemostasis, 1960
- STUDIES OF THE PLASMIN SYSTEMThe Journal of Experimental Medicine, 1958
- The Fibrinolytic Enzyme System in Normal, Hemorrhagic and Disease States1Journal of Clinical Investigation, 1958
- Estimation of the Plasminogen Activator and the Trypsin Inhibitor in Animal and Human TissuesScandinavian Journal of Clinical and Laboratory Investigation, 1957